Home > Financial Ratios > SAKAR HEALTHCARE

SAKAR HEALTHCARE
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SAKAR HEALTHCARE
Please provide your vote to see the results

SAKAR HEALTHCARE Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 21.1713.2110.299.214.22

What is the latest EV/Core EBITDA ratio of SAKAR HEALTHCARE ?

The latest EV/Core EBITDA ratio of SAKAR HEALTHCARE is 21.17 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202421.17
Mar202313.21
Mar202210.29
Mar20219.21
Mar20204.22

How is EV/Core EBITDA of SAKAR HEALTHCARE Trending?

Years EV/Core EBITDA % Change
Mar2024 21.17
60.26
Mar2023 13.21
28.38
Mar2022 10.29
11.73
Mar2021 9.21
118.25
Mar2020 4.22 -

Other Financial Ratios of SAKAR HEALTHCARE


Compare EV/Core EBITDA ratio of peers of SAKAR HEALTHCARE

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAKAR HEALTHCARE ₹727.8 Cr -2.7% -6.5% 3.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,383.0 Cr 2.6% -5.1% -6.4% Stock Analytics
DIVIS LABORATORIES ₹162,026.0 Cr -0.5% -10.1% 21.8% Stock Analytics
CIPLA ₹126,159.0 Cr 4.7% 4.8% -4.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,450.0 Cr 0.6% 5.2% 8.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,536.0 Cr 4.3% -0.7% -11.4% Stock Analytics


SAKAR HEALTHCARE Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAKAR HEALTHCARE

-2.7%

-6.5%

3.6%

SENSEX

-0%

-2.1%

1.1%


You may also like the below Video Courses